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ABSTRACT 
 
Physiological modeling is a way to better understand medical 
images, and to find some image markers of pathology. As far as 
the main hepatic tumor is concerned (Hepatocellular Carcinoma), 
the changes we try to reveal in images are mainly vascular ones. 
These modifications can be seen in Magnetic Resonance Images, 
whose visual analysis is usually performed by radiologists in 
order to detect and characterize liver lesions. We propose to 
model i) the liver and its pathological vascular changes related to 
tumoral development and ii) the MRI acquisition after injection 
of contrast product. The hepatic vascularization is modeled from 
the main branches until capillaries, including several parameters 
characterizing the tumor. The output of this physiological model 
constitutes the input of the MRI simulator. This one is based on 
the Bloch equations and images depend on the acquisition 
parameters, the tissue properties (relaxation times, proton 
density) and the contrast product propagation. 
 
Index terms: Modeling, Magnetic Resonance Imaging, 
Simulation, Liver, Cancer. 
 
1. INTRODUCTION  
 
The hepatocellular carcinoma is the most common malignant 
tumor of the liver and its incidence is continuously increasing 
[12]. Several kinds of therapy can be used to treat this tumor, but 
it is obviously of great importance to detect their appearance and 
to characterize them the most precociously than possible in order 
to optimize the treatment. Medical imaging is a tool that 
participates to the diagnosis, in addition to biological and 
histological analysis. Medical imaging (US, CT, MRI) has the 
advantage of being non invasive, compared to biopsy. Moreover 
it is very safe except in the rare cases of allergy to the contrast 
dye. 
Our objective is to reveal image markers of the tumoral 
development, in order i) to detect the lesion outbreak and ii) to 
characterize it by specifying its stage during the carcinogenesis 
process. To reach this aim, it is necessary to find relations 
between the modifications of the parameters computed in the 
image and the patho-physiological changes they reflect. This is 
all the more difficult since the measures realized in the image are 
not only reflecting tissular properties, but also acquisition 
conditions (operator, acquisition parameters – slice thickness, 
spatial and temporal resolution, kind of contrast agent and 
injection profile, etc). In order to better understand the relations 
between the images characteristics, the tissular and vascular 
properties of the liver, and the acquisition conditions, we propose 
a model-based image analysis methodology. In our preceding 
works [3] [4], this approach has been applied to hepatic CT 
images modeling. In this paper, we propose to extend it to 
dynamic MRI simulation. Indeed, it has been shown that 
dynamic MRI can provide vascular parameters that are 
representative of the tumoral evolution [14]. The bi-level model 
proposed in [10] has been improved, mainly concerning the 
blood and contrast agent propagation, at the microscopic level. A 
new Physiologically Based Pharmacokinetic Model (PBPK), 
adapted to the liver, and which takes into account some of the 
vascular properties related to the tumoral development, is 
proposed in this paper. We coupled it with the macroscopic 
model of the liver and its vascularization [9]. We also propose a 
model of MRI acquisition, based on the Bloch equations, and that 
allows us to generate dynamic hepatic MRI simulated under 
various acquisition conditions.  
 
2. CLINICAL PROBLEM 
 
Our objective is to be able to detect, in MR images, the main 
changes due to vascular modifications during tumoral 
development of the liver.  
For instance the complex flow modifications related to 
hepatocarcinogenesis (figure 1) can help to characterize the 
lesion. The main pathway of hepatocarcinogenesis is the 
progressive malignant transformation of a benign Regenerative 
Nodule (RN) in a malignant tumor, HepatoCarcinoma (HCC), in 
a cirrhotic liver. The Regenerative Nodule (RN) is made of 
normal hepatic cells, associated with an architectural disruption. 
Its vascular portal and arterial supplies are the similar to those of 
adjacent normal parenchyma. During the progressive malignant 
transformation of the nodule, we observe a rarefaction of the 
portal tracts (structures containing the hepatic arteriole and portal 
venule), together with an arterial neoangiogenesis (hatched 
region on the scheme).  
These new vessels have morphological and physiological 
characteristics that differ from normal hepatic arterioles (in gray 
on figure 1). The portal supply of the nodule decreases 
progressively until it is canceled out in the poorly-differentiated 
HCC (HCCp). The phenomena are slightly more complex, 
regarding the arterial supply (gray zone plus the hatched gray one 
corresponding to neo vessels): an initial decrease of flow is 
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observed in low grade dysplastic nodules (DNl) which then 
progressively increases due to the arterial neovascularization. For 
high grade dysplastic nodules (DNh) and well-differentiated 
HCC (HCCw) the arterial flow increase, due to neo-vessels, can 
fully compensate for the drop in flow of normal arterioles.  
 
 
Figure 1: Evolution of blood supply during hepatocarcinogenesis 
(RN: Regenerative Nodule, DNl,h: low, high grade Dysplastic 
Nodule, HCCw,m,p: well, moderate, and poorly differentiated 
HCC) [12]. 
Other microvascular properties are modified during the tumoral 
development like transport across the vessels wall. In our 
microscopic model, we took into account some of these 
parameters that constitute indicators of the tumoral stage, and 
that we would like to relate to image parameters. 
 
3. METHOD 
 
3.1. Vascular model  
 
3.1.1. Macroscopic vascular model 
In our computational model detailed in [9], the liver is 
constituted of parenchyma and vessels. The macrovascular 
network is made of 3 trees (Hepatic Artery HA, Portal Vein PV, 
Hepatic Vein HV), whose growth is simulated, considering at 
each growth cycle, the geometric (length, caliber) and 
haemodynamic properties (blood flow and pressure). This model 
is used to simulate local pathological changes, like hyper-
vascularization due to a tumor development (vascular 
modifications are mainly arterialization and capillarization). The 
contrast product propagation, in normal or tumoral tissues is 
calculated, by using all the vessels characteristics. These 3 
vascular trees are connected at the level of macro-functional units 
(“macro-cell”). A macro-cell is made of parenchyma and very 
small vessels, whose geometry is not considered, but whose 
enhancement has to be known, in order to simulate realistic MRI 
images. It is at this level that compartment modeling intervenes: 
each macro-cell is replaced by an independent pharmacokinetic 
model. 
 
3.1.2. Model of transcapillaries exchanges 
Each macro-cell is replaced by an independent five 
compartments model (figure 2) whose entries (arterial and portal 
blood flows and concentrations) depend on the corresponding 
data in the macro vascular model. Their profiles are deduced 
from the contrast product propagation in the macrovessels until 
the terminal arterioles and venules.  
This pharmacokinetic model integrates the hepatic arteriole and 
the portal venule as full compartments and not just as simple 
inputs of the model. The inputs are the terminal branches of the 
hepatic artery and the portal vein, that supply the hepatic lobule, 
considered here as the functional unit of the liver parenchyma. 
The output is the terminal hepatic venule, supplied by a capillary 
network that constitutes the sinusoidal compartment. These 
compartments do not only communicate with each other while 
the molecule is propagating. Transmembranar exchanges also 
exist between them and the interstitial fluid inside the lobule. A 
model of these exchanges was already applied by Kellen & al [8] 
in the cardiovascular system.  
Figure 2: Compartment model of the hepatic microcirculation 
Symbols: Q (flows, mL.s-1), C (concentrations, mM), V 
(volumes, mL), J (fluxes,  f stands for fluid, cm.s-1, and s for 
solute, mmol.cm-2.s-1) 
 
In this work, several pathways are considered for the solute and 
fluid exchanges. For example, sinusoids, that are a particular type 
of discontinued capillaries, present large fenestrations, in 
addition to small and large pores. In the opposite, the arterioles 
and venules are supposed to be impermeable in a normal liver. 
Some important parameters whose variations characterize the 
tumoral stage evolution are integrated. They are mainly transport 
parameters (vascular permeability, hydraulic conductivity, 
reflection coefficient) related to the molecule and to the vascular 
walls properties, but also exchange area, concentration and 
pressure gradients. 
The molecule propagation is described by the system of 
differential equations given below, where the evolution of its 
concentration in each compartment is computed as a function of 
time (V/S notations correspond to Volumes/Surfaces).  
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Concentrations in the five compartments are used to compute the 
resulting concentration in each macro-cell, and then the T1, T2 
values necessary to generate the 3D phantom needed by the MRI 
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simulator. Those new relaxation parameters (after injection of 
contrast agent) are obtained from the following equation: 
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Where R1,2 are relaxation rates (s-1), r1,2 are relaxi ities (mv M-1.s-1) 
and C(t) (mM) is the agent concentration. 
 consists in three main steps. The first one is 
ased on Bloch equations [6]. It is devoted to the simulation of 
 
3.2. Model of MRI 
 
The proposed model
b
the excitation and the relaxation processes, characterized by the 
following equations: 
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Where M(t) is the 3D magnetization vector at time t, M0 is the  
equilibrium magnetization vector, B(t) is the 3D magnetic field at 
adio frequency field. The magnetic field 
induction) related to the 
time t, T1 and T2 are the relaxation times and γ is the 
gyromagnetic ratio. 
The object is placed in the main static magnetic field and 
submitted to the r
gradients are added. The series of matrices with values of the 
magnetization vectors are thus collected. The model allows us to 
change the slice thickness, repetition time, echo time, inversion 
time, sampling interval, sampling time, frequency encoding 
range, number of frequency encoding steps, phase encoding 
range, number of phase encoding steps, etc. Moreover it enables 
to choose one of the three following MRI sequences: spin echo, 
gradient echo or inversion recovery. 
The second step was built upon the physical laws (for instance, 
Faraday’s law of electromagnetic 
received magnetic signal and to the coded and decoded signal in 
the 3-dimensional environment [11]. The resulted equation to 
simulate the received voltage is: 
∫−= dVtdMconsttE )()(  dt
Where const describes the magnetic properties of the transceiver. 
The third step consists in the image reconstruction using the fast 
d the 
n figure 3. It is possible to load and display the 3D 
, spin-
Fourier transform algorithm applied to the received signal.  
This model is implemented in the C++ language. Two additional 
modules are integrated: one for analog-digital conversion an
other to set the appropriate parameters in order to avoid problems 
with the artifacts associated to Nyquist’s law and spatial 
encoding.  
Part of the graphical user interface of our MRI model is 
displayed o
phantoms that are going to be imaged, to choose the MRI 
parameters, to perform the simulation of the images and finally to 
visualize and compare simulation results. Another advantage of 
this interface is the comfortable and clear dialog windows which 
allow watching artifacts related to the spatial encoding and the 
analog-digital conversion. These aspects make our simulator 
easier to use than already existing simulators such as SIMRI [2]. 
Furthermore, additional module, responsible for the computation 
in the grid computing environment, was created. It uses a 
multiprocessor machine with the Inifiband network and the MPI 
1.2 standard with its implementation in MVAPICH 0.9.5.  
The input of the simulator is a 3D phantom, whose voxels are 
characterized by the following parameters: proton density
lattice relaxation time (T1), spin-spin relaxation time (T2) and, 
eventually, spin-spin relaxation time with the influence of the 
magnetic field inhomogeneity (T2*). These features depend on 
the voxel composition (proportion of hepatic parenchyma, and 
blood), and are also related to the contrast product concentration, 
computed with the microscopic model presented in §3.1.2. 
 
 
Figure 3: Overview of the main window of the MRI simulator 
with some results of a given region of interest in the liver. 
 
Figure 4.a s ulated liver. 
oherence of the pharmacokinetic model was evaluated 
 
4. RESULTS AND DISCUSSION 
hows the arterial tree of the sim
C
independently from the macroscopic one, in particular conditions 
of simulation (steady-state) for three kinds of contrast agent 
molecules (Gd-DOTA (DOTAREM®, Guerbet, France), P760 
[7], Ultrasmall Particles of Iron Oxide [5] [13]). It was also 
applied to the modeling of different stages of liver 
carcinogenesis, from the healthy case to the HCC. The simulated 
concentration curves vs. time appeared to be in agreement with 
known modifications in the liver related to the 
hepatocarcinogenesis, as for example arterialization phenomenon 
(figure 4.b). 
 
 
 
a) Macrovascular model 
 
 
 
b) Microvascular model 
Fi rial vas d 
liver. b) Evolut n of the contrast product concentration in the 5 
 
The r or a 
mulated moderate-differentiated HCC, for which portal supply 
gure 4: a) Part of the arte cular tree of the simulate
io
compartments of the pharmacokinetic model (HCCm). 
esults on the right-handed graph of figure 4 are given f
si
is decreased as well as sinusoids permeability. The concentration 
in the hepatic lobule (hepatic parenchyma macro-cell when 
coupling the two models) is a weighted sum of concentrations in 
all compartments. Consequently, the global concentration in the 
tumoral hepatic tissue is also higher at the arterial phase than in 
the portal one. This is even more observable on poorly-
differentiated HCC where the portal supply is completely 
inhibited. At this state of the study, we can expect to observe 
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some contrast between tumoral and normal tissues at arterial 
phase. Indeed, T1 and T2 relaxation times are decreased with 
contrast agent concentrations and relaxivities. A new class of 
macro-cells with characteristics such as birth, death, supply, etc, 
that differ from normal macro-cells was generated in a region of 
the vascular system, to simulate a hypervascularized zone. In 
addition, transport parameters have been controlled to simulate 
more particularly a poorly-differentiated HCC: fenestrations were 
suppressed in the sinusoids to decrease their permeability; on the 
contrary, interstitial osmotic and hydrostatic pressures were 
increased in the tumoral macro-cells. 
 
 
 
a) Before injection of  
Gd-DOTA 
 
 
b)  30 seconds after injection of 
Gd-DOTA 
Figure e liv c 
physiological model (§3.1), and the MRI simulator (§3.2.) on a 
ulated MR images of the generated 3D 
hantom, with various acquisition parameters. Figure 5.a shows 
PERSPECTIVES 
In this pap els of the 
epatic vascularization are presented. They were initially 
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able 
 5: MR images of th  er simulated using the hepati
T1-weighted spin echo sequence at 1.5 T (TE=12ms, TR=300ms, 
slice thickness 3mm). 
 
Figure 5 displays sim
p
the result of a T1-weighted spin echo sequence before injection 
of a contrast agent. Such sequence is characterized by a short 
echo time TE and a short repetition time TR, thus enhancing the 
contrast on T1 parameter: tissues with longer T1 (vessels) appear 
darker. The same sequence is then applied 30 seconds after 
injection of a Gd-DOTA contrast agent (figure 5.b). As this time 
corresponds approximately to the arterial phase, the 
concentration of contrast agent is higher in the tumor than in the 
healthy tissue, the T1 of this region is then decreased, and the 
HCC appears brighter, as expected. 
 
5. CONCLUSION AND 
 
er, two models that describe two different lev
h
developed separately for evaluation, and then combined to allow 
the simulation of MR images of the liver, generated by a recently 
developed MRI simulator. The macroscopic model enables to 
simulate different pathologies of the vascular system, via 
modeling for instance hypervascularized tumors in defined 
regions of the organ, while the microscopic one is more 
specialized in molecule transport in the parenchyma. The 
simulation of MR images of tumors in the liver already showed 
promising results. The new microscopic model not only includes 
important physiological parameters that are responsible for 
changes in the vascularization. It also takes into account 
characteristics of the molecule, thus permitting to evaluate 
different kinds of molecules. The integration of hepatic cell and 
biliary compartments, in the future, will be interesting and useful 
for active transport modeling. This way, the simulation of new 
contrast agents or even therapeutic molecules will become 
possible, for instance in drug delivery studies or molecular 
design. In the case of the macroscopic model, improvements are 
under study to design more realistic vessels and macro-cells that 
would take into account tumoral tissue characteristics. On top of 
that, integration of new modules in the MRI simulator, such as 
new sequences, is foreseen. All those improvements combined 
are necessary to generate more realistic images. In addition to the 
study of new molecules and optimization of injection profiles or 
MRI sequences, image analysis is of great interest. Indeed, 
texture analysis on both simulated and real MR images of the 
liver, could explain physiological (model of the liver) parameters 
related to the phenomena we observe, and control the influence 
of physical parameters (MRI simulation).  
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